Articles tagged with Flu Vaccines
A new approach predicts the antigenic evolution of circulating influenza viruses, enabling a closer match for vaccine viruses and potentially improving vaccine effectiveness. The method identifies clusters of viruses featuring novel mutations, which can predict the molecular characteristics of next seasonal influenza virus.
A study of over 20,000 patients with heart failure found that flu vaccination was associated with a 35% lower risk of developing dementia. Those who received the flu vaccine more than three times had a 55% lower risk. The researchers suggest that vaccination may reduce inflammation and prevent brain damage
Scientists developed a novel strategy to predict how circulating influenza viruses will evolve, which may help create better seasonal flu vaccines. The approach involves simulating mutations in lab and mapping patterns using antigenic cartography, revealing clusters of unique mutations that match natural evolution.
Researchers found that differences in immune cell parameters correlate with an individual's immune response to the flu vaccine. People who show a better antibody response after vaccination have higher levels of specific proteins on dendritic cells and more B cells, indicating improved immunity against flu.
Researchers found that babies whose moms receive flu vaccinations while pregnant have a significantly reduced risk of acquiring influenza during their first six months of life. The study, published in Pediatrics, showed that infants born to vaccinated mothers had a 70 percent reduction in laboratory-confirmed flu cases and an 80 percen...
A study published in PLOS ONE identifies distinct patterns of seasonal influenza activity in the tropics and subtropics, grouping countries into eight geographical zones. These zones can inform targeted flu vaccination programs, providing valuable insights into optimal delivery timing and vaccine formulation.
Researchers found that morning flu vaccinations led to significantly larger increases in antibody concentration one month after vaccination, compared to afternoon vaccinations. The study suggests a potential strategy to improve vaccination efficiency without additional cost to the healthcare system.
The new study found that higher levels of antibody against neuraminidase protein were better predictors of protection against flu infection and its side effects. Participants with high levels of HA antibodies experienced lower incidence of mild-to-moderate influenza, but not necessarily less severe symptoms.
A new study found that women who received seasonal trivalent influenza vaccine during pregnancy were 51 percent less likely to experience a stillbirth than unvaccinated mothers. The study's results support the safety of influenza vaccination during pregnancy and suggest that it protects against stillbirth.
Researchers at Sanofi Pasteur have published pre-clinical data on a novel, computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses. The vaccine strategy elicited a broad antibody response against seasonal and pandemic isolates in mice, demonstrating its potential as a 'subtype universal' vaccine.
Researchers at UGA and Sanofi Pasteur have developed a vaccine that protects against multiple strains of seasonal and pandemic H1N1 influenza in mouse models. The COBRA vaccine was designed to recognize H1N1 viruses isolated within the last 100 years, offering broader cross-protection.
A study published in Annals of Internal Medicine found that quitting smoking abruptly is more likely to lead to lasting abstinence compared to quitting gradually. The researchers found that patients who quit abruptly were 25% more likely to stop smoking in both the short and long term.
Researchers from Kaiser Permanente found that flu vaccination during hospitalization does not increase the risk of emergency department visits or subsequent hospitalizations. Vaccinated patients also did not have an increased risk of fever or laboratory tests checking for infection.
Research led by the University of Pittsburgh School of Medicine found that state laws mandating influenza immunization for health care workers increased their vaccination rates from 22.5% to 50.9% between 2000 and 2011. The study suggests that stronger laws, including mandates and education, lead to higher vaccination rates.
A study by UTMB found that APPs prescribed short-acting inhalers and consulted with pulmonary specialists more often, leading to lower ER visits for COPD and higher follow-up rates. However, they had lower vaccination rates and less frequent clinic visits after hospitalization compared to physicians.
A new study found that flu vaccination is associated with a lower risk of developing atrial fibrillation, a heart condition linked to increased stroke risk. The study suggested that flu infection may trigger an inflammatory response that increases the risk of AF.
Researchers studied 36 pregnant women to determine if T-follicular helper cell response varies by trimester after vaccination. The results show that the immune system's response is greatest during the first trimester, suggesting immunologic changes may affect vaccine effectiveness.
Researchers developed an infant-friendly flu vaccine using a natural protein that provides four to five times the protection against influenza compared to traditional adjuvants. This breakthrough could lead to safer and more effective vaccinations for premature infants.
Kansas State University researchers developed a vaccine protecting against multiple US avian influenza strains, including H5N1, H5N2 and H5N8. The NDV-H5Nx vaccine can be administered through water or embryonated eggs, offering a potential solution for mass vaccination of poultry.
Researchers identified molecular signatures that predict immune protection in response to flu vaccination, with elderly individuals showing high levels of monocytes and low antibody-producing B cells. This study provides insight into potential mechanisms underlying reduced vaccine efficacy in older adults.
A York University study found that vaccination strategies should be adjusted based on region-specific characteristics, such as age demographics and virus transmission rates. Early vaccination leads to better public health outcomes, including reduced infection rates, hospitalizations, and stress on healthcare systems.
A prime-boost H7N9 influenza vaccine concept has shown promising results in a small clinical trial, demonstrating the potential for a single dose to provide protection. The vaccine, which combines a live but weakened virus with an inactivated booster, elicited a robust immune response in both young and older adults.
A recent survey found that only 42.7% of US hospitals require flu vaccination for all healthcare providers, leaving many staff members unprotected against the virus. This poses a significant risk to patients, particularly those with weakened immune systems.
Researchers developed a simple method to track and predict viral evolution based on whole-genome sequences of influenza viruses. By identifying genetic variants that change the structure of influenza proteins, they found that many strains used in vaccines during previous seasons lacked these markers.
Yale researchers developed a high-dose flu vaccine strategy that lowered infection rates by 64% among patients with immune system cancers. The novel dosing schedule improved protection against all flu strains in 66% of patients, offering promising results for cancer patient populations.
Researchers created a machine learning framework that predicts vaccine efficacy on an individual basis using genetic signatures. The framework demonstrated high accuracy in predicting yellow fever and flu vaccine responses.
Researchers found that statins may hinder immune response to flu vaccine and lower vaccine effectiveness in older adults, suggesting potential implications for flu vaccine recommendations and guidelines. The studies analyzed data from nearly 7,000 adults over 65 in four countries, including the US.
Australian researchers have found a way to boost influenza A vaccine effectiveness by adding an adjuvant, which stimulates both innate and adaptive immunity. The additive provides cross-protective capabilities, reducing the ability of the virus to infect cells and spread.
A new study published in JAMA found that flu vaccination can prevent up to 57% of hospitalizations due to influenza pneumonia. The research used data from over 2,700 patients and showed that the vaccine not only prevents symptoms but also serious complications like pneumonia requiring hospitalization.
Research suggests extending flu vaccine administration to 5-16 year old children is the most cost-effective option, reducing disease burden in the general population. Universal vaccination of all low-risk individuals over 2 years could achieve the highest net benefit.
A new study found that high-dose flu shots significantly reduced hospitalizations among older nursing home residents during the influenza season. The study showed a 1.2% difference in admission rates between those who received high-dose vaccine and standard dose vaccine, resulting in thousands fewer hospitalizations.
A study published in JAMA found that more than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination. The study used data from 2,767 patients hospitalized with community-acquired pneumonia during three consecutive influenza seasons.
A study published in JAMA found that patients with influenza-associated pneumonia are less likely to have received a flu vaccination compared to those with non-influenza pneumonia. The study estimated a 57% lower odds ratio of vaccination among cases hospitalized with influenza-associated pneumonia.
A study found that counties with higher flu vaccination rates among adults under 65 had a 21% lower chance of elderly adults being diagnosed with flu-related illness. Community-wide vaccination may boost protection provided by individual vaccination.
A study of over 1 million Medicare recipients found that flu vaccines with a high match rate to the prevalent strain reduced pneumonia hospitalizations by 4.2% and deaths by 2.0%. The study estimated lives saved and prevented hospitalizations annually in long-stay nursing home residents.
Researchers at the University of Wisconsin-Madison have developed a new method for making flu vaccines using cell culture, which could lead to faster and more efficient vaccine production. This technology could potentially replace traditional egg-based vaccine production methods, which are limited by avian influenza outbreaks.
Researchers have made a major advance toward creating an effective, long-lasting flu vaccine by inducing broadly neutralizing antibodies in animal models. The study's findings show that the vaccine candidate can produce powerful 'broadly neutralizing antibodies' against many influenza subtypes.
A recent study found that influenza vaccines offer moderate, sustained protection up to 6 months post-vaccination, suggesting yearly vaccination may be prudent. Administering vaccines early in the fall can still prevent the greatest number of infections.
A new Brown University study analyzed nursing home records to show that flu vaccinations significantly reduce deaths and hospitalizations among the elderly. The study found a 50-percentage point increase in match rate for A/H3N2 strain resulted in saving 2,560 lives and preventing 3,200 hospitalizations.
Johns Hopkins researchers study nasal spray flu vaccine in human nasal tract cells to determine optimal weakening or strengthening of the virus. They find that by adjusting nine mutations, a stronger vaccine can be created for older adults while still protecting children under two, offering new hope for effective flu vaccines.
Researchers create a virus-like particle vaccine cocktail that expresses different subtypes of the hemagglutinin protein, providing cross-protective immunity against multiple subtypes. The study shows that 95% of mice vaccinated with the investigational cocktail were protected against eight different influenza strains.
A phase 2 trial found that AS03 and MF59 adjuvants increased immune responses to an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest antibody response. The study suggests AS03 as a first-line adjuvant for H7N9 vaccines in adults.
A new virus-like particle vaccine has been developed to protect against a wide variety of influenza viruses. The vaccine was shown to provide significant protection against many different flu strains, including avian H5N1 and H7N9 viruses, which have caused many human cases and deaths in recent years.
A new vaccine patch made of dissolvable material has been shown to be effective in protecting against flu infection, with an immune reaction equal to or stronger than traditional needle-delivered vaccines. The patch is easy to use without medical personnel, making it ideal for developing countries.
Researchers at Rockefeller University discovered a new mechanism to create more effective and efficient vaccines against the flu virus. By harnessing modified antibodies, they were able to elicit broad protection against multiple strains of the virus.
Researchers at The Wistar Institute identified specific mutations in H3N2 viruses that made the 2014-2015 flu vaccine less effective. Antigenic drift, a phenomenon where viruses accumulate mutations to evade immune response, was found to be a key factor.
A single mutation in the H3N2 virus helped it evade the immune system's defenses, making last year's flu vaccine less effective. Researchers have identified this mutation as a key factor in the mismatch between the vaccine strain and circulating strains.
A consortium led by Massachusetts General Hospital has launched a $5.2 million project to develop an RNA-based vaccine against Q fever, a disease affecting US troops in Iraq and Afghanistan. The VaxCelerate process aims to rapidly develop vaccines for emerging infectious diseases.
A study in PLOS Medicine predicts that vaccinating Thai children with seasonal flu vaccine will reduce approximately 3,000 deaths annually. The policy is considered cost-effective according to WHO criteria.
A new study finds that measles virus has rigid surface proteins that can't tolerate mutations, making it less prone to evolution than the flu virus. This difference in protein stability may explain why measles only requires a two-dose vaccine during childhood for lifelong immunity.
Patients aged 9-26 are more likely to get HPV vaccinated after receiving reminders via electronic health records during appointments. The study found that these prompts significantly increased vaccination rates, especially among young African-American women.
A new Veterans Affairs study found that the high-dose flu vaccine provides stronger protection against flu-related hospitalizations and deaths for those 85 and older, while standard vaccines may be effective for younger seniors. The study included over 165,000 patients and tracked hospitalization and death rates.
A study by the University of Louisville found that children with neurological disorders experience a higher risk of flu complications, yet vaccination rates remain suboptimal. Parents and healthcare providers often have misconceptions about the vaccine's safety and effectiveness.
A new Ebola vaccine has been shown to be highly effective and safe in monkeys, using an experimental platform that primes the immune system with the full complement of viral proteins. The vaccine was developed by researchers at the University of Wisconsin-Madison and may offer a promising alternative to existing vaccines.
A new flu vaccine that includes four strains of inactivated influenza has been found to be more protective than a similar vaccine containing only three strains. The addition of the fourth strain increases the chance the vaccine will match the circulating flu B strains without compromising protection against other strains.
A comparative analysis by MIT researchers reveals mutations in the Indian H1N1 flu viruses that make them distinct from the 2009 vaccine strain. The study highlights the need for updated vaccination strategies to account for potential new viruses.
A team of researchers is using Twitter to gather information on vaccine refusal patterns, combining traditional survey techniques with social media analysis. The study aims to gain insights into people's reasoning about vaccines and how these reasons vary among communities.
Scientists have identified antibodies isolated from individuals with seasonal flu vaccinations that neutralize H7N9 and other influenza strains, providing broad protection. These antibodies account for a small percentage of the total immune response but show promise as potential therapeutics.
A recent study published in The Lancet found that Tamiflu significantly shortens the duration of flu symptoms by about one day and reduces respiratory infections by 44%., Researchers analyzed data from over 4,300 patients and found the drug also decreased hospital admissions by 63%.
A study found that only 54% of nursing home employees received an influenza vaccination, despite the high susceptibility of elderly residents to the virus. Inaccurate beliefs about vaccination and influenza among staff also contributed to low vaccination rates.